Award Notice NAICS 32541

SPE2D2-22-D-0150 P00009 to invoke Option Year 4 SPE2D2-22-D-0150 P00008 - This modification hereby incorporates the attached bilateral agreement incorporating clause 52.222-90, Addressing DEI Discrimination by Federal Contractors (DEVIATION 2026-O0040, REVISION 1) (APR 2026). SPE2D2-22-D-0150 P00007 to invoke Option Year 3 SPE2D2-22-D-0150 P00006 Mass Modification based on Executive Orders. SPE2D2-22-D-0150 P00005 to invoke Option Year 2 SPE2D2-22-D-0150 P00003 to invoke Option Year 1 SPE2D2-22-D-0150 P00002 To incorporate Drug Supply Chanin Act (DCSA) language into solicitation for subject contract. SPE2D2-22-D-0150 P00001 To incorporate FAR 52.204-27 Prohibtion on a Bytedance Covered Application (June 2023) into subject contract. Oxycodone HCL/Acetaminophen Tablets contract award SPE2D2-22-D-0150 Line Items 0001 through 0005.

Notice ID: 4aca076cbdbf474ea4f758f9b7d61f50 · View on SAM.gov ↗